Medidata Chief Medical Officer Ed Ikeguchi to Discuss Future of Clinical Trial Technology and Deliver Hands-On EDC Training with Medidata’s Rave 5.4 platform
Medidata Chief Medical Officer Ed Ikeguchi to Discuss Future of Clinical Trial Technology and Deliver Hands-On EDC Training with Medidata?s Rave 5.4 platform
Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that it will be hosting a five-day seminar with the Chinese State Food and Drug Administration focused on increasing clinical trials efficiencies through innovative technology. Co-sponsored by the Training Center of China and led by Medidata's Chief Medical Officer Ed Ikeguchi, the seminar will be held in Beijing from October 8-12, 2005.
For the past 20 years, China?s pharmaceutical industry has maintained a double-digit growth rate on a year-by-year basis, elevating the need for new technologies that streamline clinical trial processes. More than 400 clinical trials experts from the regulatory agency, pharmaceutical sponsors and state-approved investigative sites throughout China are expected to attend the Medidata seminar, where Ikeguchi will discuss the future of clinical trial technology. Attendees will receive a detailed tutorial on the features and benefits of Medidata's Rave 5.4 electronic clinical data capture and management platform and learn the critical role technology plays in increasing clinical trials efficiencies, promoting better decision-making, and ultimately bringing life-enhancing products to market more effectively.
"We have witnessed remarkable strides in the area of clinical technology in order to evolve the market and accommodate recent growth," said Zheng Qing-Shan, director of the Anhui Provincial Center for Drug Clinical Development and Chairman of China's Journal of Clinical Pharmacology and Therapeutics. "Our collaboration with Medidata will provide hands-on training with the most sophisticated clinical data capture and management system in the world and introduce new ways to simplify clinical trial processes starting at the user level."
"In the field of drug discovery and development, China is quickly moving from imitation to innovation, and clinicians are anticipating the need to be armed with the most advanced tools that will support this transformation," said Ikeguchi. "Medidata?s Rave solution was designed for clinical site investigators and data monitors, providing the ability to connect users and share vital information across multiple locations. Our seminar will offer practical training that highlights the value our technology can bring to all constituencies."
About Medidata Solutions Worldwide
Medidata Solutions helps the world's leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market - on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions - broad client base and deep clinical experience provide value for the world's leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.